Related Experiment Video
Updated: Jun 12, 2026

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
Published on: November 16, 2016
Abstract:
Telithromycin is a macrolide antibiotic with a negative risk-benefit balance. Its efficacy is no better than that of other macrolides. Telithromycin carries a risk of serious adverse effects, including loss of consciousness, QT prolongation, severe liver damage, aggravation of myasthenia gravis, and a high risk of drug interactions. In Finland, a 7-year pharmacovigilance review identified 20 reports of visual disorders among patients taking telithromycin, including blurred vision, accommodation disorder and diplopia, mainly in young patients and women. Visual disorders occurred in about 1% of patients receiving telithromycin in clinical trials. They were generally moderate, brief and reversible. These visual disorders may result from reversible paralysis of the ciliary body due to telithromycin. In practice, these visual disorders, which can be dangerous when driving or operating heavy machinery, add to the already long list of adverse effects of telithromycin.They are yet another reason not to use telithromycin, but rather a safer macrolide such spiramycin.
Insights
Telithromycin, a macrolide antibiotic, presents significant safety concerns, including serious adverse effects and visual disturbances. Due to its negative risk-benefit profile, safer alternatives like spiramycin are recommended.
Area of Science:
- Pharmacology
- Ophthalmology
- Drug Safety
Background:
- Telithromycin is a macrolide antibiotic.
- Macrolides are commonly prescribed for bacterial infections.
- Concerns exist regarding telithromycin's safety profile and efficacy compared to other macrolides.
Purpose of the Study:
- To evaluate the risk-benefit balance of telithromycin.
- To investigate adverse effects associated with telithromycin use.
- To highlight visual disorders as a specific adverse event.
Main Methods:
- Review of pharmacovigilance data over 7 years in Finland.
- Analysis of clinical trial data regarding adverse events.
- Assessment of the mechanism and clinical significance of visual disturbances.
Main Results:
- Telithromycin has a negative risk-benefit balance, with efficacy comparable to other macrolides.
- Serious adverse effects include liver damage, QT prolongation, and drug interactions.
- A 7-year review identified 20 reports of visual disorders (blurred vision, accommodation disorder, diplopia), affecting approximately 1% of patients, primarily young women. These effects are generally reversible but can be dangerous.
Conclusions:
- Telithromycin's adverse effect profile, including visual disturbances potentially due to ciliary body paralysis, warrants caution.
- The risks associated with telithromycin outweigh its benefits, especially when safer macrolides like spiramycin are available.
- Telithromycin should be avoided in favor of alternative antibiotics with a better safety profile.
Related Concept Videos
Photoreceptors and Visual Pathways
Trichomoniasis
Therapeutic Drug Monitoring: Affecting Factors
Total Internal Reflection Fluorescence Microscopy
Inhibitors of Bacterial DNA Synthesis
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...